COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
CMS released guidance for non-federal governmental plans implementing the Families First Coronavirus Response Act requirement to cover COVID-19 diagnostic testing and certain related items and services without cost-sharing, prior authorization or other medical management restrictions during the…
The Food and Drug Administration reissued emergency use authorizations that revise policy on the types of respirators that can be decontaminated for reuse.
This document outlines changes made by the Food and Drug Administration to its policy governing the decontamination and reuse of certain respirators during the COVID-19 public health emergency.
The Food and Drug Administration released COVID-19 performance data for four more antibody test kits. The results come from the first collaboration between FDA, the National Institute of Health’s National Cancer Institute, Centers for Disease Control and Prevention and Biomedical Advanced Research…
The Food and Drug Administration this week released guidance for institutional review boards seeking clarity regarding the key factors and procedures they should consider when reviewing requests by physicians and others for individual patient access to investigational drugs.
Social distancing interventions started earlier in the COVID-19 epidemic appear to delay the epidemic curve while interventions started later appear to flatten it, according to a new study published in the Centers for Disease Control and Prevention’s Emerging Infectious Diseases Journal.
The Centers for Medicare & Medicaid Services recently issued new guidance implementing the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group, established by the Families First Coronavirus Response Act.
CMS Issued New Guidance for States on the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group
The Centers for Medicare & Medicaid Services (CMS) released guidance on June 2 for states implementing the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group, established by the Families First Coronavirus Response Act.
The Food and Drug Administration recently created an online compendium page of COVID-19 resources for health care professionals.
The Food and Drug Administration authorized the emergency use of two new products designed to respond to the COVID-19 ventilator shortage.